← Back to Search

N/A

Hepatitis C Treatment in Underserved Populations

N/A
Waitlist Available
Led By Brian R. Edlin, MD
Research Sponsored by Brian Edlin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up quarterly up to 10 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to examine the feasibility, safety, and effectiveness of treating persons who are actively using illicit drugs for hepatitis C using a collaborative, multidisciplinary, integrated care model. We hypothesize that by maximizing facilitators and minimizing barriers to treatment we can enable drug users to receive effective treatment for hepatitis C.

Eligible Conditions
  • Drug Addiction
  • Chronic Hepatitis C

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~quarterly up to 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and quarterly up to 10 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sustained virologic response, defined as an undetectable serum HCV RNA level 24 weeks after completion of antiviral therapy.
Secondary study objectives
adherence to antiviral therapy
entry into treatment for another unaddressed medical or psychiatric condition
entry into treatment for substance use
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Collaborative multidisciplinary integrated careExperimental Treatment1 Intervention
Collaborative, multidisciplinary, integrated care for hepatitis C

Find a Location

Who is running the clinical trial?

State University of New York - Downstate Medical CenterOTHER
66 Previous Clinical Trials
12,117 Total Patients Enrolled
Weill Medical College of Cornell UniversityOTHER
1,092 Previous Clinical Trials
1,154,756 Total Patients Enrolled
Brian EdlinLead Sponsor
Brian R. Edlin, MDPrincipal InvestigatorWeill Medical College, Cornell University
~1 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top